Eubacterium coprostanoligenes alleviates chemotherapy-induced intestinal mucositis by enhancing intestinal mucus barrier

• Published in: Acta pharmaceutica Sinica. B Vol. 14; no. 4; pp. 1677 - 1692
• Main Authors: Bai, Dongsheng, Zhao, Jiawei, Wang, Runde, Du, Jiaying, Zhou, Chen, Gu, Chunyang, Wang, Yuxiang, Zhang, Lulu, Zhao, Yue, Lu, Na
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.04.2024; Elsevier
• Subjects: AUF1; Chemotherapy; Eubacterium coprostanoligenes; MUC2; Mucositis; Original; Eubacterium coprostanoligenes; AUF1; Chemotherapy; Mucositis; MUC2
• ISSN: 2211-3835; 2211-3843
• DOI: 10.1016/j.apsb.2023.12.015

Chemotherapy-induced mucositis represents a severe adverse outcome of cancer treatment, significantly curtailing the efficacy of these treatments and, in some cases, resulting in fatal consequences. Despite identifying intestinal epithelial cell damage as a key factor in chemotherapy-induced mucositis, the paucity of effective treatments for such damage is evident. In our study, we discovered that Eubacterium coprostanoligenes promotes mucin secretion by goblet cells, thereby fortifying the integrity of the intestinal mucus barrier. This enhanced barrier function serves to resist microbial invasion and subsequently reduces the inflammatory response. Importantly, this effect remains unobtrusive to the anti-tumor efficacy of chemotherapy drugs. Mechanistically, E. copr up-regulates the expression of AUF1, leading to the stabilization of Muc2 mRNA and an increase in mucin synthesis in goblet cells. An especially significant finding is that E. copr activates the AhR pathway, thereby promoting the expression of AUF1. In summary, our results strongly indicate that E. copr enhances the intestinal mucus barrier, effectively alleviating chemotherapy-induced intestinal mucositis by activating the AhR/AUF1 pathway, consequently enhancing Muc2 mRNA stability. The potential mechanism of Eubacterium coprostanoligenes alleviating chemotherapy-induced mucositis. E. copr activates AhR in goblet cells to promote AUF1 transcription, which binds and stabilizes Muc2 mRNA to increase the intestinal mucus layer to alleviate chemotherapy-induced mucositis. [Display omitted]